Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 6404528

Iscador.

View original source ↗Export metadata ↓

Abstract

After careful study of the literature and other information available to it, the American Cancer Society does not have evidence that treatment with Iscador, an extract of mistletoe, results in objective benefit in the treatment of cancer in human beings. Lacking such evidence, the American Cancer Society would strongly urge individuals afflicted with cancer not to participate in treatment with Iscador.

Explore related subjects

American Cancer SocietyAntineoplastic Agents, PhytogenicEuropeHumansPlant ExtractsPlant ProteinsUnited StatesUnited States Food and Drug AdministrationJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Iscador.. https://doi.org/10.3322/canjclin.33.3.186

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Evaluation of the American Cancer Society's breast cancer-related documents by cancer survivors.

BACKGROUND: In an attempt to address the informational needs of female breast cancer survivors, the American Cancer Society (ACS) develops and distributes written documents. Although this educational effort has been well received, little attention has been given to the suitability of the materials themselves. METHODS: A random sample of 812 survivors was derived from callers to the ACS National Cancer Information Center (NCIC) from July to December of 2000. The participants then rated the three most commonly distributed breast cancer information documents on five dimensions 1). presentation, 2). satisfaction, 3). understanding, 4). anxiety, and 5). impact. RESULTS: . Participants responded favorably to four of the five rating categories. Conclusions. The evidence suggests that the three materials had positive health outcomes and were well received by the survivors.

American Cancer Society↗